Article Versions Notes

Puig N, Flores-Montero J, Burgos L, Cedena M-T, Cordón L, Pérez J-J, Sanoja-Flores L, Manrique I, Rodríguez-Otero P, Rosiñol L, et al. Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers. 2021; 13(19):4924. https://doi.org/10.3390/cancers13194924

Puig, Noemí, Juan Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, and et al. 2021. "Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma" Cancers 13, no. 19: 4924. https://doi.org/10.3390/cancers13194924

Puig, N., Flores-Montero, J., Burgos, L., Cedena, M.-T., Cordón, L., Pérez, J.-J., Sanoja-Flores, L., Manrique, I., Rodríguez-Otero, P., Rosiñol, L., Martínez-López, J., Mateos, M.-V., Lahuerta, J.-J., Bladé, J., San Miguel, J. F., Orfao, A., & Paiva, B., on behalf of the PETHEMA/GEM Cooperative Group and EuroFlow. (2021). Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers, 13(19), 4924. https://doi.org/10.3390/cancers13194924